Richard R. Kerr
FDA panel’s vote on TRT draws reaction from urologists
FDA panel’s vote on TRT draws reaction from urologists
An FDA advisory committee has voted to restrict indications for testosterone replacement therapy and require additional clinical trials to test the safety of the drugs, decisions that have drawn mixed reactions from urologists.
Approval of enzalutamide pre-chemo a ‘game changer’
Approval of enzalutamide pre-chemo a ‘game changer’
The FDA’s approval of enzalutamide (XTANDI) to treat metastatic castration-resistant prostate cancer (CRPC) in the pre-chemotherapy setting is a potential game changer for both patients and treating physicians, especially urologists, according to leaders in the prostate cancer field.
Tomato-rich diet may lower prostate cancer risk
Men who eat over 10 portions a week of tomatoes have an 18% lower risk of developing prostate cancer, according to a newly published study from the United Kingdom.
Genomic variation in IC/BPS based on bladder capacity
Patients with interstitial cystitis/bladder pain syndrome who have low bladder capacity have a significantly different gene expression profile than both IC/BPS patients with normal bladder capacity and those without the condition, researchers reported in a recently published pilot study.
Deaths rise with outpatient urologic surgeries
As a number of common urologic surgeries have shifted from the inpatient to outpatient setting, potentially preventable deaths have increased following complications, the authors of a recently published study reported.
Prostate cancer screening still common in older men
A significant number of older men with limited life expectancy continue to undergo routine prostate cancer screening, researchers say.
Epigenetic test may cut unneeded repeat PCa biopsies
Two independent published trials have validated the performance of an epigenetic test that could provide physicians with a better tool to help eliminate unnecessary repeat prostate biopsies.
IOM report, AUA at odds over GME funding solutions
The federal system for financing physician training and residency programs needs to be overhauled to ensure that the United States is producing the physicians that the nation needs, according to a new Institute of Medicine (IOM) report that the AUA says makes recommendations that would have a negative effect on teaching hospitals and fails to acknowledge a doctor shortage across all specialties.
Men too often receive T for ‘soft’ indications
To gain an endocrinologist’s perspective on current issues in testosterone therapy and hypogonadism, Urology Times interviewed Rebecca Z. Sokol MD, MPH, professor of obstetrics and gynecology and medicine at the Keck School of Medicine of the University of Southern California, Los Angeles.
Genomic test helps guide decisions on RT after RP
A genomic tool for prostate cancer appears to provide physicians and patients with improved decision making about the use of radiation therapy after radical prostatectomy.